Chief Pharmacist at Ohio State Board of Pharmacy
Employing Organization
Team
Decision makers at Ohio State Board of Pharmacy
Chief Data Officer
Chief Information Officer
Chief Legal Counsel
Chief of Investigations
Key decision makers in the same organization
Organization Signals
Board meetings, strategic plans, and buyer signals from Jenni Wai’s organization
The Board convened to consider summary suspensions as authorized by the Ohio Revised Code. The primary agenda item involved a discussion regarding the activities of a Terminal Distributor of Dangerous Drugs licensee, resulting in a successful vote to summarily suspend the license of Optimal Balance Pharmacy LLC. The meeting concluded shortly after this action was taken.
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
Verified emails & phones
Accuracy-guaranteed data
Job-change & title updates
Never lose a contact
The committee reviewed the compliance status of several individuals. One individual made their third annual appearance to maintain compliance with a prior Board Order. The committee also discussed a probation violation, conducted a review of a probationer, and tabled a request from another probationer for further information.
The Board conducted multiple adjudication hearings regarding pharmacist license reinstatements and disciplinary actions, resulting in the reinstatement of licenses for two pharmacists under probationary terms, the permanent revocation of a pharmacist's license due to fraud convictions, and the summary suspension of several pharmacy technician and distributor licenses. The Board also reviewed and approved various regulatory resolutions, including appointments to the 2026 Controlled Substances Advisory Committee, delays in the enforcement of outpatient electronic positive identification requirements, and temporary policies for neonatal parenteral nutrition. Additionally, the Board reviewed and approved several settlement agreements regarding regulatory compliance and pharmacy law violations.
The Board convened to consider and act upon the summary suspension of licenses for several terminal distributors of dangerous drugs. Specifically, the Board voted unanimously to summarily suspend the licenses for Evoluciona Pharma, FarmaKeio, and Striker Pharmacy, LLC, following presentations of factual information regarding their activities.
Extracted from official board minutes, strategic plans, and video transcripts.
Organization signals
Board meetings and buying signals
Salesforce & HubSpot sync
Native two-way integration
